期刊文献+

护理干预联合多烯磷脂酰胆碱治疗脂肪肝的临床疗效观察 被引量:3

Observation on Clinical Effect of Nursing Intervention Combined with Polyene Phosphatidyl Choline in Treatment of Fatty Liver
下载PDF
导出
摘要 目的观察护理干预联合多烯磷脂酰胆碱治疗脂肪肝的临床疗效。方法脂肪肝患者90例,按随机数字表法分为两组:对照组44例给予还原型谷胱甘肽、肌苷、维生素C等一般治疗和常规护理,治疗组46例在对照组的基础上给予多烯磷脂酰胆碱静滴和护理干预。监测治疗前后肝功能、血脂及肝脏B超。结果治疗组肝功能改善明显,ALT、AST、γ-GT、TC、TG水平明显降低,显著优于对照组(P<0.05);治疗组总有效率为84.8%,对照组为63.4%,治疗组疗效优于对照组(P<0.05)。结论护理干预联合多烯磷脂酰胆碱治疗脂肪肝安全、有效。 Objective To observe the clinical effect of nursing intervention combined with polyene phosphatidyl choline (PPC) in the treatment of fatty liver. Methods Ninety patients with fatty liver were randomly divided into two groups according to random number table, the control group (n = 44) received conventional nursing care and routine treatment with reduced glutathione,inosine and vitamin C, the treatment group (n = 46) received the same treatment as controls besides nursing invention and intravenous infusion of PPC. Patients' liver function and blood fat were monitored, and B ultrasound of liver was performed in both groups before and after treatment. Results Liver function improved significantly while ALT,AST,~/-GT,TC and TG decreased significantly in treatment group,which were superior to those in control group(P 〈0.05);Total effective rate of treatment group was 84.8% while that of control group was 63.4%, the efficacy of treatment group was superior to that of control group (P 〈 0.05). Conclusion Nursing intervention combined with PPC in the treatment of fatty liver is safe and effective.
出处 《广西医学》 CAS 2013年第2期163-165,共3页 Guangxi Medical Journal
关键词 脂肪肝 护理干预 多烯磷脂酰胆碱 临床疗效 Fatty liver Nursing intervention Polyene Phosphatidyl choline Clinical efficacy
  • 相关文献

参考文献4

二级参考文献47

  • 1胡国平,刘凯,王甦,唐红,赵连三.多烯磷脂酰胆碱(易善复)治疗慢性肝炎的系统评价[J].中国循证医学杂志,2005,5(7):543-548. 被引量:44
  • 2王莉.慢性肝炎的分类——诊断、分级、分期[J].国外医学(消化系疾病分册),1995,15(2):100-102. 被引量:1
  • 3马安林,刘淑娥,刘霞,徐潜,郭新珍,王泰龄.双环醇与多烯磷脂酰胆碱治疗酒精性脂肪肝的临床病理比较[J].临床肝胆病杂志,2006,22(4):272-275. 被引量:16
  • 4王家良 刘鸣.循证医学[M].北京:人民卫生出版社,2001.177-188.
  • 5Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis[J]. Hepatology, 1981; 1(3): 43.
  • 6Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: Is blinding necessary[J]? Control Clin Trials, 1996; 17(34): 1-12.
  • 7Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials[J]. JAMA, 1995; 273(5): 408-412.
  • 8Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M. Does quality of reports of randomized trials affect estimates of intervention efficacy reported in Meta-analyses[J]? Lancet,1998; 352(9128): 609-613.
  • 9Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses[J]. Annals of Internal Medicine, 2001; 135(11) : 982-989.
  • 10Perter J, Jenkins BP, Portmann A.L, Eddleston W.F, Roger Williams. Use of polyunsaturated phosphatidyl choline in HBsAg negative chronic active hepatitis: results of prospective double blind controlled trial[J]. Liver, 1982; 2(3): 77-81.

共引文献152

同被引文献22

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部